Introduction to Cytotechnology
Theory and Practice of Cytopreparatory Techniques I
and II
Gynecologic Cytopathology
Cytomorphology of cells from the
female genital system, inflammatory changes, human papilloma
virus related changes, early stages of cervical cancer,
dysplasia, carcinoma in situ, squamous carcinoma, endocervical
and endometrial adenocarcinoma
Non-Gynecologic Exfoliative Cytopathology
Cytomorphology of benign and malignant conditions of respiratory,
gastrointestinal, urinary and central nervous systems
and body cavity fluids
Fine Needle Aspiration Cytology
Cytomorphology of benign and malignant conditions of lung,
breast, thyroid, salivary gland, liver, pancreas, kidney,
adrenal gland, bone, soft tissue, skin and lymph nodes
Laboratory Operations
Fixation, processing and staining of specimens for cytodiagnosis.
Diagnostic Laboratory
Screening and diagnosing gynecologic, non-gynecologic
and fine needle aspiration specimens
Special Studies
Image analysis, fluorescent in situ hybridization, immunocytochemical
marker studies, special stains, cytogenetics and laboratory
management
Clinical Internship
Three weeks rotation in Laboratory Corporation of America
at Houston and
One week rotation in University of Texas Medical Branch
at Galveston
Upon successful completion of our
Program you will be awarded a Certificate of Completion
and will be eligible to take the national certification
exams given by the Board of Registry of the American Society
of Clinical Pathologists.
Why M. D. Anderson Cancer Center?
In a recent nationwide survey published in U.S. News and
World Report, M.D. Anderson Cancer Center was named number
two in the nation in cancer care. One of the models for
federally designated comprehensive cancer centers, this
425 bed Hospital is internationally recognized for its
exceptional strength in patient care, research, and educational
programs. Since M. D. Anderson Cancer Center is one of
the world's largest cancer centers the students have the
opportunity to examine and diagnose all types of cancer
cells of the human body from a large population of cancer
patients.